Summary
This is an Early Day Motion tabled in the House of Commons on 28 February 2022, which calls on the Government to implement the recommendations of the Independent Medicines and Medical Devices Safety Review in full, including paying compensation to people disabled by Sodium Valproate.
Content
What is an Early Day Motion?
Early Day Motions are motions submitted for debate in the House of Commons for which no day has been fixed, and as such very few are debated. They are used to put on record the views of individual MPs or to draw attention to specific events or campaigns. By attracting the signatures of other MPs, they can be used to demonstrate the level of parliamentary support for a particular cause or point of view.
Early Day Motion 1012: Implementation of the Independent Medicines and Medical Devices Safety Review recommendations
This Early Day Motion was sponsored by Cat Smith MP, Christian Wakeford MP, Ben Lake MP, David Lidden MP and Yasmin Qureshi MP. It reads as follows:
That this House notes that sodium valproate can cause serious problems in a developing baby; that 10 per cent of babies whose mothers take sodium valproate during pregnancy are at risk of having a birth defect, and up to 40 per cent have problems with development and learning as they grow; welcomes the July 2020 Independent Medicines and Medical Devices Safety Review; and calls on the Government to implement its recommendations in full, including paying compensation to people disabled by Sodium Valproate.
Related reading
- Independent Medicines and Medical Devices Safety Review, First Do No Harm, July 2020
- Independent Medicines and Medical Devices Safety Review: A joint letter from the Association for Children Damaged by Hormone Pregnancy Tests, Sling The Mesh and In-Fact, 17 February 2022
- Patient Safety Learning, A year on from the Cumberlege Review: Initial reflections on the Government’s response, 23 July 2021
Recommended Comments
Create an account or sign in to comment